Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway

International Journal of Oncology

Volumn 43, Issue 6, 2013, Pages 1951-1959

  Xu, Marvin Xuejun ^a   Zhao, Linlin ^b   Deng, Chaoyang ^b   Yang, L U ^b   Wang, Yang ^c   Guo, Tao ^d   Li, Lifang ^c   Lin, Jianping ^e   Zhang, Lirong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Shanghai Televector Biomedical Ltd Co   (China)

^c HENAN UNIVERSITY   (China)

^d SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^e NANKAI UNIVERSITY   (China)

Author keywords

Curcumin; Hepatocellular carcinoma; Wnt signaling pathway

Indexed keywords

AXIN; BETA CATENIN; CURCUMIN; DISHEVELLED 2; LYMPHOID ENHANCER FACTOR 1; T CELL SPECIFIC TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CARCINOMA CELL; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; COMPUTER SIMULATION; CONTROLLED STUDY; CYCLIN D1 GENE; DOWN REGULATION; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CELL CARCINOMA; ONCOGENE C MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMULATION; VASCULOTROPIN GENE; WNT SIGNALING PATHWAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; APOPTOSIS; AXIN PROTEIN; AXIN SIGNALING COMPLEX; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CURCUMIN; CYCLIN D1; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; LIVER NEOPLASMS; MOLECULAR DOCKING SIMULATION; PHOSPHOPROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84891928848     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2107     Document Type: Article

References (30)

1. Aberle H, Bauer A, Stappert J, Kispert A and Kemler R: beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804, 1997.
2. Baeg GH and Perrimon N: Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr Opin Cell Biol 12: 575-580, 2000.
3. Banerjee M, Tripathi LM, Srivastava VM, Puri A and Shukla R: Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 25: 213-224, 2003.
4. Case DA, Darden TA, Cheatham TE III, et al : Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2012.
5. Daugherty RL and Gottardi CJ: Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology 22: 303-309, 2007.
6. Giommarelli C, Zuco V, Favini E, Pisano C, Dal Piaz F, De Tommasi N and Zunino F: The enhancement of antiproliferative and proapoptotic activity of HDAC inhibitors by curcumin is mediated by Hsp90 inhibition. Cell Mol Life Sci 67: 995-1004, 2010.
7. Guillen-Ahlers H: Wnt signaling in renal cancer. Curr Drug Targets 9: 591-600, 2008.
8. Itasaki N and Hoppler S: Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev Dyn 239: 16-33, 2010.
9. Janssens N, Janicot M and Perera T: The Wnt-dependent signaling pathways as target in oncology drug discovery. Invest New Drugs 24: 263-280, 2006.
10. Kakarala M, Brenner DE, Korkaya H, et al: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122: 777-785, 2010.
11. Kohn AD and Moon RT: Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38: 439-446, 2005.
12. Kurashina R, Ohyashiki JH, Kobayashi C, Hamamura R, Zhang Y, Hirano T and Ohyashiki K: Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Cancer Lett 284: 62-70, 2009.
13. Lammi L, Arte S, Somer M, et al: Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74: 1043-1050, 2004.
14. Laurent-Puig P, Legoix P, Bluteau O, et al: Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 120: 1763-1773, 2001.
15. Li Y, Kong D, Wang Z, Ahmad A, Bao B, Padhye S and Sarkar FH: Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prev Res (Phila) 4: 1495-1506, 2011.
16. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004.
17. Miquel J, Bernd A, Sempere JM, Diaz-Alperi J and Ramirez A: The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 34: 37-46, 2002.
18. Mosimann C, Hausmann G and Basler K: Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10: 276-286, 2009.
19. Niehrs C and Acebron SP: Mitotic and mitogenic Wnt signalling. EMBO J 31: 2705-713, 2012.
20. Nusse R: Wnt signaling in disease and in development. Cell Res 15: 28-32, 2005.
21. Peifer M and Polakis P: Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609, 2000.
22. Prasad CP, Rath G, Mathur S, Bhatnagar D and Ralhan R: Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling. Chem Biol Interact 181: 263-271, 2009.
23. Shiina H, Igawa M, Breault J: The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin Cancer Res 9: 2121-2132, 2003.
24. Zhang Y, Appleton BA, Wiesmann C, Lau T, Costa M, Hannoush RN and Sidhu SS: Inhibition of Wnt signaling by disheveled PDZ peptides. Nat Chem Biol 5: 217-219, 2009.
25. Sun L, Tian Z and Wang J: A direct cross-talk between interferon-gamma and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells. Brain Behav Immun 24: 220-228, 2010.
26. Veeman MT, Axelrod JD and Moon RT: A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 5: 367-377, 2003.
27. Vivekanand P and Rebay I: Intersection of signal transduction pathways and development. Annu Rev Genet 40: 139-157, 2006.
28. Yamamoto H, Oue N, Sato A, Hasegawa Y, Matsubara A, Yasui W and Kikuchi A: Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29: 2036-2046, 2010.
29. Zeng X, Huang H, Tamai K, et al: Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, disheveled and axin functions. Development 135: 367-375, 2008.
30. Zeng X, Tamai K, Doble B, et al: A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873-877, 2005